Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre (MAHSC), 6Th Floor St Mary's Hospital, Oxford Road, Manchester, M13 9WL, UK.
Orphanet J Rare Dis. 2022 Mar 4;17(1):110. doi: 10.1186/s13023-022-02239-3.
Inherited vitreoretinopathies arise as a consequence of congenital retinal vascularisation abnormalities. They represent a phenotypically and genetically heterogeneous group of disorders that can have a major impact on vision. Several genes encoding proteins and effectors of the canonical Wnt/β-catenin pathway have been associated and precise diagnosis, although difficult, is essential for proper clinical management including syndrome specific management where appropriate. This work aimed to investigate the molecular basis of disease in a single proband born to consanguineous parents, who presented with microphthalmia, persistent foetal vasculature, posterior lens vacuoles, vitreoretinal dysplasia, microcephaly, hypotelorism and global developmental delay, and was registered severely visually impaired by 5 months of age.
Extensive genomic pre-screening, including microarray comparative genomic hybridisation and sequencing of a 114 gene panel associated with cataract and congenital ophthalmic disorders was conducted by an accredited clinical laboratory. Whole exome sequencing (WES) was undertaken on a research basis and in vitro TOPflash transcriptional reporter assay was utilised to assess the impact of the putative causal variant.
In the proband, WES revealed a novel, likely pathogenic homozygous mutation in the cadherin-associated protein beta-1 gene (CTNNB1), c.884C>G; p.(Ala295Gly), which encodes a co-effector molecule of the Wnt/β-catenin pathway. The proband's parents were shown to be heterozygous carriers but ophthalmic examination did not detect any abnormalities. Functional assessment of the missense variant demonstrated significant reduction of β-catenin activity.
This is the first report of a biallelic disease-causing variation in CTNNB1. We conclude that this biallelic, transcriptional inactivating mutation of CTNNB1 causes a severe, syndromic form of microphthalmia, persistent foetal vasculature and vitreoretinal dysplasia that results in serious visual loss in infancy.
遗传性玻璃体视网膜病变是由先天性视网膜血管异常引起的。它们代表了一组表型和遗传上异质性的疾病,对视功能有重大影响。已经发现几个编码经典 Wnt/β-catenin 通路蛋白和效应物的基因与该病相关,尽管精确诊断具有挑战性,但对于适当的临床管理至关重要,包括在适当情况下进行综合征特异性管理。本研究旨在调查一名由近亲父母所生的先证者的疾病分子基础,该患者表现为小眼球、持续性胎儿血管、后晶状体空泡、玻璃体视网膜发育不良、小头畸形、眼距过近和全面发育迟缓,且在 5 个月大时被严重视力障碍登记。
通过认证的临床实验室,对先证者进行了广泛的基因组预筛查,包括微阵列比较基因组杂交和与白内障和先天性眼部疾病相关的 114 个基因的测序。全外显子组测序(WES)是在研究基础上进行的,并利用体外 TOPflash 转录报告基因测定来评估假定的致病变异的影响。
在该先证者中,WES 揭示了一种新的、可能的致病性同型纯合突变,位于钙粘蛋白相关蛋白β-1 基因(CTNNB1)中,c.884C>G;p.(Ala295Gly),该基因编码 Wnt/β-catenin 通路的一个共效分子。先证者的父母被证明是杂合携带者,但眼部检查未发现任何异常。对该错义变异的功能评估显示β-catenin 活性显著降低。
这是 CTNNB1 中存在双等位基因致病变异的首例报道。我们得出结论,这种 CTNNB1 的双等位基因、转录失活突变导致严重的、综合征性小眼球、持续性胎儿血管和玻璃体视网膜发育不良,导致婴儿期严重视力丧失。